Clinical Pregnancy Rate Clinical Trial
Gonadotropin-releasing hormone analogue (GnRH-a) is a synthetic decapeptide compound which can down-regulate pituitary function causing a temporary low estrogen state. Since endometriosis is an estrogen-dependent disease, the use of long-acting GnRH-a can control the growth of endometriosis by inhibiting ovary function.Some scholars have found that, for adenomyosis patients who received a super long protocol (pretreatment of long-acting GnRH-a for 1-2 months) in IVF treatment, the pregnancy outcome is comparable to that of the controls with normal uterus. Thus, the aim of this study is to compare the clinical pregnancy rate in patients treated with GnRH-a for 1, or 2 months.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03350646 -
Does the Volume of the Embryo Culture Medium During Embryo Transfer Affects the IVF Outcomes?
|
N/A | |
| Completed |
NCT04175990 -
IVF Outcome Following Progestogen Ovarian Stimulation
|
Phase 1 | |
| Completed |
NCT03162315 -
The Value of Progesterone for the Timing of the Embryo Transfer in IVF/ICSI: a Prospective Randomised Trial
|
N/A | |
| Recruiting |
NCT02496754 -
The Application of a New Ovarian Stimulation Protocol in IVF
|
N/A | |
| Recruiting |
NCT06165367 -
Hyaluronan-enriched Medium and Euploid Blastocyst Transfers
|
N/A | |
| Terminated |
NCT00737984 -
Improving the Pregnancy Rate With Endometrial Sampling Before Intrauterine Insemination
|
N/A |